LAS-OI01 is a novel LNP (Lipid Nanoparticle) vaccine adjuvant and immunotherapeutic agent that combines a dual-adjuvant molecular system comprising CpG 2007 (a TLR9 agonist) and a TLR7/8 activator. This combination elicits robust and long-lasting cellular and humoral immune responses, significantly enhancing the immunogenicity of vaccines. The LNP lipid nanoparticles optimize the uptake and activation of immune cells by efficiently delivering antigens and adjuvant molecules, thereby improving the strength and durability of immune responses.
This adjuvant system is suitable for a wide range of animal vaccines, including those for pigs, cattle, sheep, horses, chickens, ducks, geese, fish, dogs, and cats. It demonstrates particularly notable efficacy in vaccines against complex pathogens such as bacteria, viruses, fungi, and parasites. Research indicates that LNP lipid nanoparticles can enhance the immunostimulatory effects of CpG 2007 by 5-10 times, while the inclusion of the TLR7/8 activator further synergistically boosts Th1-type immune responses and antibody production.
In summary, the LNP lipid nanoparticle adjuvant system, with its efficient delivery capability and dual-adjuvant synergy, provides powerful technical support for animal vaccines and immunotherapy. It excels in scenarios requiring strong immune protection against complex pathogen infections.
Cat.No
DC67256
Name
LAS-OI01
Chemical Properties
CAS
Formula
MW
Storage
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
References
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
